Intravenous Alcohol Administration Using BrAc Method in Healthy Subjects With and Without a Family History of Alcoholism
Conditions
Alcoholism
What is the purpose of this trial?
The proposed study is the first to explore the contribution of brain glutamate systems, a major target of ethanol in the brain, to the vulnerability to develop alcoholism. This study may lead to an enhanced understanding of the underlying neurobiological mechanism in high risk individuals that may lead to the transition from moderate to excessive use of alcohol.
Participation Guidelines
- Age:
- 21 Years - 30 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- VA Connecticut Healthcare System
Yale University - Dates:
- March 2001
- Last Updated:
- February 14, 2013
- Study HIC#:
- 0304025194
Clinicaltrials.gov ID: NCT00612352
